menu search

Will boston scientific (bsx) beat q2 earnings estimates?

Boston Scientific (BSX) is expected to have registered strong growth in EMEA within structural heart, including TAVR, WATCHMAN and other interventiona...

July 20, 2023, 2:24 pm

Bridgebio pharma: positive attr-cm treatment data leads to other 2023 catalysts

Primary endpoint met in BridgeBio Pharma, Inc.'s phase 3 ATTRibute-CM study, which used acoramidis for the treatment of patients with transthyretin am...

July 17, 2023, 6:42 pm

Bridgebio pharma stock soars on heart disease drug study results

BridgeBio Pharma Inc shares surged 69% to $30.78 in late-morning trading on Monday after the commercial-stage biopharmaceutical company announced that...

July 17, 2023, 11:33 am

: bridgebio’s stock rockets 66% on news of positive results from late-stage trial of attr-cm treatment

BridgeBio Pharma Inc.’s stock BBIO rocketed 66% in premarket trade Monday, after the company announced positive results in a late-stage trial of a t...

July 17, 2023, 11:32 am

Why is bridgebio (bbio) stock up 63% today?

BridgeBio Pharma (NASDAQ: BBIO ) stock is climbing higher on Monday as investors react to results from a Phase 3 clinical trial. These results come f...

July 17, 2023, 10:04 am

Bridgebio's stock rockets 66% on news of positive results from late-stage trial of attr-cm treatment

BridgeBio Pharma Inc.'s stock BBIO, +5.26% rocketed 66% in premarket trade Monday, after the company announced positive results in a late-stage trial ...

July 17, 2023, 7:32 am

Lianbio announces phase 3 explorer-cn data accepted for late-breaking presentation at the european society of cardiology congress 2023

SHANGHAI, China and PRINCETON, N.J., July 17, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovati...

July 15, 2023, 6:59 am

: redlining was outlawed 55 years ago, but it’s still hurting heart health today

Living in a formerly redlined neighborhood is linked to higher risk of stroke, heart attack and other cardio...

July 14, 2023, 8:19 pm

Lly stock alert: what to know as eli lilly acquires versanis bio

Eli Lilly (NYSE: LLY ) stock is a hot topic among traders on Friday after the company announced its acquisition of Versanis Bio . Versanis Bio is a cl...

July 14, 2023, 10:29 am

Eli lilly to acquire versanis bio, expanding obesity-treatment pipeline

Eli Lilly and Co. LLY, -1.34% will acquire Versanis Bio, a private clinical-stage biopharma company focused on new treatments for ...

July 14, 2023, 8:14 am

Why shares of silk road medical are dropping wednesday

Silk Road Medical is a medical device maker specializing in cardiovascular therapies. The company repor...

July 12, 2023, 12:35 pm

Cvrx to report second quarter 2023 financial and operating results and host conference call on july 25th, 2023

MINNEAPOLIS, July 11, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing...

July 11, 2023, 4:30 pm

Marpai collaborates with nuvoair to offer value-based cardiopulmonary care to self-funded employer health plans

Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), an AI-powered Third-Party Administrator (TPA) transforming self-funded employer healt...

July 5, 2023, 12:29 pm

Ani pharmaceuticals is undervalued when considering their unadvertised pipeline

ANIP Pharmaceuticals has not yet published a pipeline of products under development or out-licensed, leaving investors in the dark about future revenu...

July 5, 2023, 12:51 am

Alnylam (alny) announces fda committee onpattro snda review date

Alnylam (ALNY) reports that the FDA has set Sep 13, 2023, as the day for the meeting of the Advisory Committee to review its sNDA application for pati...

July 3, 2023, 11:27 am

High-dose statin therapy reduces mace risk in stable cad patients with high cardiac troponin levels

Japan: High-dose statin treatment may reduce the risk of major adverse cardiovascular events (MACE) in ...

July 3, 2023, 7:14 am

Verve therapeutics gains 20.74% in june as ark funds invest

Verve, which was founded in 2018 and went public in June 2021, is developing gene-editing treatments, delivered through a single, intravenous infusion...

June 30, 2023, 7:21 am

Abbott laboratories is a hold due to its high valuation

I analyzed Abbott Laboratories, a healthcare company with a diversified portfolio that includes pharmaceuticals, diagnostic products, nutritional prod...

June 29, 2023, 1:47 am

Bristol myers (bmy) heart drug camzyos wins ec approval

Bristol Myers (BMY) receives EC approval for Camzyos for treating symptomatic (New York Heart Association, NYHA, class II-III) obstructive hypertrophi...

June 27, 2023, 12:48 pm

Reviva pharmaceuticals to be added to russell microcap® index

CUPERTINO, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clin...

June 26, 2023, 10:00 am


Search within

Pages Search Results: